A Trigger-based Design for Evaluating the Safety of In Utero Antiretroviral Exposure in Uninfected Children of Human Immunodeficiency Virus-Infected Mothers
Paige L. Williams(Cancer Research And Biostatistics), Denise L. Jacobson(Cancer Research And Biostatistics), Jennifer S. Read(Foundation for Human Potential), Yong Huo(Sun Yat-sen University), Kenneth Rich(University of Illinois Chicago), George K. Siberry(Columbia University Irving Medical Center), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Canan Yıldırım(Harvard University Press), Ray Griner(Cancer Research And Biostatistics), Russell B. Van Dyke(Tulane University), Katherine Tassiopoulos(Harvard University), George R. Seage(Unknown), Rohan Hazra
Cited by 39
Related Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896